research BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF-Mutant Thyroid Cancer
Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.
Salisbury, MD, United States
São Paulo, SP, Brazil
Belém, PA, Brazil
Scottsdale, AZ, United States
Belo Horizonte, MG, Brazil
Goiânia, GO, Brazil



